Advanced search
Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 43, 2024 - Issue 3
Submit an article Journal homepage
129
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Probable IGG4 related ophthalmic disease presenting with uveitis

George S. P. Murphya Sussex Eye Hospital, University Hospitals Sussex, Brighton, UKCorrespondence[email protected]
View further author information
,
Pav A Goundera Sussex Eye Hospital, University Hospitals Sussex, Brighton, UKView further author information
,
Catriona D. Goodb Department of Neuroradiology, University Hospitals Sussex, Brighton, UKView further author information
,
Vijay Hajelac Department of Rheumatology, University Hospitals Sussex, Brighton, UKView further author information
,
Michael Koenigd Department of Cellular Pathology, University Hospitals Sussex, Brighton, UKView further author information
,
Edward Hughesa Sussex Eye Hospital, University Hospitals Sussex, Brighton, UKView further author information
&
Saul Rajaka Sussex Eye Hospital, University Hospitals Sussex, Brighton, UKView further author information
 show all
Pages 354-358 | Received 19 Aug 2022, Accepted 02 Oct 2022, Published online: 17 Oct 2022

References

  • Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. doi:10.3109/s10165-011-0571-z.
  • Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–1192. doi:10.1038/modpathol.2012.72.
  • Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982–984. doi:10.1007/s00535-003-1175-y.
  • Chen LY, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104:444.
  • Ebbo M, Daniel L, Pavic M, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore). 2012;91(1):49–56.
  • NHS England clinical commissioning policy: rituximab for immunoglobulin G4-related disease (IgG4-RD). https://www.england.nhs.uk/wp-content/uploads/2016/12/clin-comm-pol-16057P.pdf. Accessed March 10, 2022.
  • Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43(6):806–817. doi:10.1016/j.semarthrit.2013.11.008.
  • Najem K, Derzko-Dzulynsky L, Margolin EA. IgG4-related disease presenting as panuveitis without scleral involvement. J Ophthalmic Inflamm Infect. 2017;7:1–4.
  • Lee CS, Harocopos GJ, Kraus CL, et al. IgG4-associated orbital and ocular inflammation. J Ophthalmic Inflamm Infect. 2015;5(1):1–8. doi:10.1186/s12348-015-0047-y.
  • Prayson RA. Immunoglobulin G4-related ophthalmic disease presenting as uveitis. J Clin Neurosci. 2015;22:1848–1849.
  • Das D, Deka P, Verma G, et al. IgG4-related intraocular inflammation masquerading as ciliary body melanoma in a young girl. Indian J Ophthalmol. 2016;64(8):601. doi:10.4103/0301-4738.191510.
  • Kosakai A, Ito D, Yamada S, Ideta S, Ota Y, Suzuki N. A case of definite IgG4-related pachymeningitis. Neurology. 2010;75(15):1390–1392. doi:10.1212/WNL.0b013e3181f73685.
  • Paulus YM, Cockerham KP, Cockerham GC, Gratzinger D. IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report. Ocul Immunol Inflamm. 2012;20:375–377.
  • Reynolds GL, Norris JH, Aslam S, Sharma S. IgG4-related disease presenting as posterior scleritis and vitritis, progressing to multifocal orbital involvement. BMJ Case Rep. 2017;2017:bcr-2017–219568.
  • Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529–533. doi:10.1080/14397595.2020.1859710.
  • Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol (Copenhagen). 2013;91:694–700.
  • Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020;369:m1067.
  • Khosroshahi A, Wallace Z, Crowe J, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688–1699.
  • Kubota T, Katayama M, Moritani S, Yoshino T. Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment. Am J Ophthalmol. 2013;155:373–379.
  • Decker L, Crawford AM, Lorenzo G, Stippler M, Konstantinov KN, SantaCruz K. IgG4-related hypophysitis: case report and literature review. Cureus. 2016;8(12). doi:10.7759/cureus.907.
  • Elmaci I, Altinoz MA, Akdemir G, et al. Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case. Clin Neurol Neurosurg. 2020;200:106342. doi:10.1016/j.clineuro.2020.106342.
  • Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014;71(6):785–793. doi:10.1001/jamaneurol.2014.243.
  • Brown JWL, Martin PJ, Thorpe JW, et al. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunol. 2014;271(1–2):66–68. doi:10.1016/j.jneuroim.2014.03.012.
  • Ilyas-Feldmann M, Prüß H, Holtkamp M. Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis. Seizure. 2021;86:138–143. doi:10.1016/j.seizure.2021.02.010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.